Piu Medical SpAMIL:PMED 13 EBITDA Margin % is 7.66% as of Jun. 2025, which is 38% below its 10-year median of 12.28. GuruFocus rates MIL:PMED with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Piu Medical SpA ranks worse than 56.01% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Piu Medical SpA's EBITDA for the
six
months ended in Jun. 2025 was €1.02 Mil. Piu Medical SpA's Revenue for the
six
months ended in Jun. 2025 was €13.36 Mil. Therefore, Piu Medical SpA's EBITDA margin for the quarter that ended in Jun. 2025 was 7.66%.
Piu Medical SpA (MIL:PMED) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Piu Medical SpA EBITDA Margin % Related Terms
Piu Medical SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Piu Medical SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA EBITDA Margin % Chart
Piu Medical SpA Annual Data
Trend
Dec23
Dec24
Dec25
EBITDA Margin %
13.95
12.28
5.09
Piu Medical SpA Semi-Annual Data
Dec23
Dec24
Jun25
Dec25
EBITDA Margin %
0.00
0.00
7.66
6.92
Piu Medical SpA EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Piu Medical SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Piu Medical SpA EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Piu Medical SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Piu Medical SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA (MIL:PMED) has a EBITDA Margin % of 7.66% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Piu Medical SpA and its competitors. This is 38% below median its historical median of 12.28. Over the past decade, Piu Medical SpA's EBITDA Margin % has ranged from 5.09 to 13.95. According to the industry distribution chart, Piu Medical SpA ranks #373 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 56%.
Is Piu Medical SpA's EBITDA Margin % too high?
Piu Medical SpA's current EBITDA Margin % of 7.66% is 38% below median its 10-year median of 12.28. Over the past 10 years, this metric has ranged from a low of 5.09 to a high of 13.95. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Piu Medical SpA's value of 7.66% is 25.2% below this industry median. Based on the distribution chart, Piu Medical SpA ranks #373 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Piu Medical SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Piu Medical SpA ranks #373 out of 666 companies for EBITDA Margin %. This places Piu Medical SpA in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Piu Medical SpA's value of 7.66% is 25.2% below this benchmark. Historically, Piu Medical SpA's own EBITDA Margin % has ranged from 5.09 to 13.95 over the past decade. While the company's 10-year median is 12.28 vs. the industry median of 10.24, Piu Medical SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Piu Medical SpA's current EBITDA Margin % of 7.66% is 25.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Piu Medical SpA and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Piu Medical SpA's current EBITDA Margin % is 7.66%, which is 38% below median its own 10-year median of 12.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (MIL:PMED) has a current EBITDA Margin % of 7.66%. The current EBITDA Margin % is 7.66%, which is 38% below median its 10-year median of 12.28 and 25.2% below the Healthcare Providers & Services industry median of 10.24. Piu Medical SpA's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Piu Medical SpA (MIL:PMED), the current EBITDA Margin % is 7.66% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
13GF Score
Get the complete analysis for MIL:PMED
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PMED has been successfully added to your 